Vanguard Group Inc Adicet Bio, Inc. Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,272,522 shares of ACET stock, worth $2.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,272,522

Previous 3,272,522 -0.0%

Holding current value

$2.16 Million

Previous $2 Million 32.77%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$0.45 - $0.82 $29,988 - $54,644	66,640 Added 2.08%	3,272,522 $2 Million
Q3 2024 Nov 13, 2024	BUY	$1.07 - $1.63 $113,340 - $172,659	105,926 Added 3.42%	3,205,882 $4.62 Million
Q2 2024 Aug 13, 2024	SELL	$1.21 - $2.4 $32,212 - $63,892	-26,622 Reduced 0.85%	3,099,956 $3.75 Million
Q1 2024 May 10, 2024	BUY	$1.76 - $3.45 $2.54 Million - $4.97 Million	1,441,503 Added 85.55%	3,126,578 $7.35 Million
Q4 2023 Feb 14, 2024	BUY	$1.11 - $1.89 $14,084 - $23,982	12,689 Added 0.76%	1,685,075 $3.18 Million
Q3 2023 Nov 14, 2023	BUY	$1.37 - $3.4 $5,069 - $12,580	3,700 Added 0.22%	1,672,386 $2.29 Million
Q2 2023 Aug 14, 2023	SELL	$2.13 - $7.13 $46,397 - $155,312	-21,783 Reduced 1.29%	1,668,686 $4.05 Million
Q1 2023 May 15, 2023	SELL	$5.52 - $9.23 $3,438 - $5,750	-623 Reduced 0.04%	1,690,469 $9.74 Million
Q4 2022 Feb 10, 2023	BUY	$7.72 - $21.27 $1.48 Million - $4.08 Million	191,833 Added 12.8%	1,691,092 $15.1 Million
Q3 2022 Nov 14, 2022	BUY	$13.43 - $18.74 $3.55 Million - $4.95 Million	264,049 Added 21.38%	1,499,259 $21.3 Million
Q2 2022 Aug 12, 2022	BUY	$10.26 - $20.81 $1.68 Million - $3.4 Million	163,555 Added 15.26%	1,235,210 $18 Million
Q1 2022 May 13, 2022	SELL	$11.53 - $19.97 $2.02 Million - $3.5 Million	-175,478 Reduced 14.07%	1,071,655 $21.4 Million
Q4 2021 Feb 14, 2022	BUY	$7.37 - $17.49 $1.33 Million - $3.15 Million	180,314 Added 16.9%	1,247,133 $21.8 Million
Q3 2021 Nov 12, 2021	BUY	$6.29 - $9.93 $37,727 - $59,560	5,998 Added 0.57%	1,066,819 $8.36 Million
Q2 2021 Aug 13, 2021	BUY	$9.19 - $15.93 $9.75 Million - $16.9 Million	1,060,821 New	1,060,821 $10.9 Million

Others Institutions Holding ACET

# of Institutions

Shares Held

53.3M

Call Options Held

Put Options Held

View Full List

About Adicet Bio, Inc.

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $26.4M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

More about ACET

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Adicet Bio, Inc. Transaction History